The role played by a normal endogenous corticotrophin secretion in the mechanism by which adrenocortical steroidogenic response to ACTH increases as a result of previous administration of the peptide, was assessed by repeated ACTH administration in 25 patients under prolonged cortico-therapy and in 13 patients with anterior hypophyseal insufficiency.
sponse to ACTH does not require continuous endogenous corticotrophin secretion. They further suggest that intermittent corticotrophin therapy may be more adequate in promoting recovery of adrenocortical function on steroid withdrawal than a schedule consisting of daily ACTH administration, since the latter is thought to slow down hypothalamic-pituitary activity because of concomitant sustained enhancement of steroidogenesis.
After acute administratiaon of corticotrophin (ACTH) to normal subjects or after surgery, by which endogenous secretion of the peptide is enhanced, the secretory responsiveness of the adrenal cortex to ACTH remains increased for a few days (Thorn et al. 1953; Kolanowski et al. 1972 Kolanowski et al. , 1975a ; this has been referred to as potentiation of the adrenocortical response. It appeared of in¬ terest to assess whether this ACTH-induced adrenocortical hypersensitivity requires maintenance of the endogenous ACTH secretion. Normal subjects given dexamethasone for a few days still show the potentiation phenomenon (Kolanowski et al. 1975a ). The present report raises the question whether the phenomenon can also be observed in patients suffering from a chronic lack of endogenous corticotrophin secretion on the basis of anterior pituitary failure or because of long-term treatment with pharmacological doses of glucocorticoids. To this end, ACTH was infused in such patients on 2 to 4 consecutive days, or at 2-day intervals between successive stimulations, in order to allow comparison with normal subjects under the same experimental conditions (Kolanowski et al. 1975a ). (unconjugated) cortisol, 17-ketogenic steroids and creatinine were measured as described previously (Kolanowski et al. 1975a greater response (Fig. 3) , even when the second infusion took place 3 days after the first one (P < 0.001 for plasma cortisol, urinary excretion of cortisol and 17-ketogenic steroids). ACTH was also infused either on 2 consecutive days (group 3) or with a 2-day interval (group 4) into patients suffering from anterior hypophyseal insufficiency. Again, the response to the second infusion was enhanced in both instances (Fig. 4) . The magnitude of the adrenocortical response to the second ACTH infusion was greater when ACTH was infused on 2 consecutive days (group 3, P < 0.001 for the increase in cortisolaemia and in urinary 17-keto¬ genic steroid excretion) than when 2 days had elapsed between both ACTH infusions (group 4, P < 0.05 for the same parameters). The same conclusion can be drawn from cortisol excretion profile, even though it was documented in only 3 patients of each group. (Table 2 ) from one day to the next (P < 0.001 for the three parameters measured). On the other hand, when ACTH was given on days 1, 4, 7 and 10, the response to the second stimula¬ tion was again significantly increased (P < 0.01 for all parameters); some change was still perceptible from day 4 to day 7 but no further enhancement was observed comparing days 7 and 10 (Tables 1 and 3 ). This is remarkably (Kolanowski et al. 1975a ); this was observed by Bransome (1968) in control and dexamethasone-treated guinea pigs.
The trophic influence exerted by ACTH on the adrenal cortex is unlikely to account entirely for the potentiation phenomenon. Firstly, despite a pro¬ longed period of deficient ACTH secretion the responsiveness pattern docu¬ mented for normal subjects could be reproduced (Kolanowski et al. 1975a (Christy et al. 1956; Carreon et al. 1960; Landon et al. 1965; Jacobson et al. 1968 ). On the other hand, there was no significant correlation between the daily dose of steroids and the resulting adrenocortical hypore-sponsiveness. Other reports dealing with this subject (London et al. 1965; Jacobson et al. 1968; Westerhof et al. 1970) came to a different conclusion but the discrepancy may be merely apparent since the amounts of steroid given daily to patients must be considered. Only for daily doses of prednisone (or equivalent) ranging from 2.5 to 10 mg was some relationship found (London et al. 1965; Westerhof et al. 1970; Carter 8c (Graber et al. 1965 ). The same schedule of ACTH treatment may also deserve attention when corticotrophin therapy is preferred to steroids, since intermit¬ tent ACTH administration with 2-day intervals does not induce a sustained adrenocortical hyperactivity either in normal subjects (Kolanowski et al. 1975a) or even in patients treated chronically (Nelson et al. 1966) .
In this respect, the use of the octadecapeptide analogue of corticotrophin (ACTHi_i8) 
